The Potential Role of Noninvasive Glucose Monitoring in the Management of People with Type 2 Diabetes

Abstract

Background:

Continuous glucose monitoring (CGM) has come a long way and is standard for patients with type 1 diabetes and many with type 2 diabetes. Several attempts to establish noninvasive glucose monitoring, that is, measuring glucose without puncturing the skin, have not been successful yet.

Method:

A different approach is the monitoring of volatile organic compounds in breath.

Results:

This addresses a number of limitations of current invasive glucose monitoring techniques. This should enhance compliance, adherence, clinical outcomes, and quality of life. It might also reduce costs associated with CGM.

Conclusions:

A recent publication in this journal indicates the clinical value of this approach by presenting data from a clinical study. The respective pros and cons will be discussed briefly.